{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:03:30Z","timestamp":1748837010817,"version":"3.41.0"},"reference-count":16,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ol.2016.4123","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T13:46:16Z","timestamp":1453124776000},"page":"1933-1935","source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment of Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient using 3,4-diaminopyridine: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"JAE-WON","family":"HYUN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SU-HYUN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IN HYE","family":"JEONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEUNG TAE","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HO JIN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,18]]},"reference":[{"key":"key20180108094145_b1-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1971.tb30750.x","article-title":"Quantal components of end-plate potentials in the myasthenic syndrome","volume":"183","author":"Lambert","year":"1971","journal-title":"Ann NY Acad Sci"},{"key":"key20180108094145_b2-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: From clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol"},{"key":"key20180108094145_b3-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"key20180108094145_b4-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.2012.06769.x","article-title":"Treatment in Lambert-Eaton myasthenic syndrome","volume":"1275","author":"Maddison","year":"2012","journal-title":"Ann NY Acad Sci"},{"key":"key20180108094145_b5-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1200\/JCO.2008.17.5133","article-title":"Screening for small-cell lung cancer: A follow-up study of patients with Lambert-Eaton myasthenic syndrome","volume":"26","author":"Titulaer","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108094145_b6-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(25)22023-7","article-title":"Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction","volume":"227","author":"Thomsen","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108094145_b7-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM198912073212303","article-title":"3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome","volume":"321","author":"McEvoy","year":"1989","journal-title":"N Engl J Med"},{"key":"key20180108094145_b8-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.54.3.603","article-title":"A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome","volume":"54","author":"Sanders","year":"2000","journal-title":"Neurology"},{"journal-title":"Memorandum No 45","article-title":"Medical Research Council: Aids to the examination of the peripheral nervous system","year":"1967","key":"key20180108094145_b9-ol-0-0-4123"},{"key":"key20180108094145_b10-ol-0-0-4123","first-page":"59","author":"Oh","year":"1998","journal-title":"Repetitive Nerve Stimulation Test Principles of Clinical Electromyography: Case studies"},{"key":"key20180108094145_b11-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3988\/jcn.2012.8.4.305","article-title":"A case of lambert-eaton myasthenic syndrome with small-cell lung cancer and transient increase in anti-acetylcholine-receptor-binding antibody titer","volume":"8","author":"Lee","year":"2012","journal-title":"J Clin Neurol"},{"key":"key20180108094145_b12-ol-0-0-4123","first-page":"95","article-title":"Marked improvement of Lambert-Eaton syndrome with the chemotherapy of small cell lung carcinoma","volume":"24","author":"Shin","year":"2006","journal-title":"J Korean Neurol Assoc"},{"key":"key20180108094145_b13-ol-0-0-4123","first-page":"393","article-title":"A case of remitted Lambert-Eaton Myathenic syndrome with small cell lung carcinoma following chemotherapy and radiotherapy","volume":"8","author":"Lee","year":"1990","journal-title":"J Korean Neurol Assoc"},{"key":"key20180108094145_b14-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.40.10.1552","article-title":"Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma","volume":"40","author":"Chalk","year":"1990","journal-title":"Neurology"},{"key":"key20180108094145_b15-ol-0-0-4123","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/mus.21422","article-title":"3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS","volume":"40","author":"Oh","year":"2009","journal-title":"Muscle Nerve"},{"key":"key20180108094145_b16-ol-0-0-4123","first-page":"76","article-title":"A case of Lambert-Eaton myasthenic syndrome with small cell lung cancer, treated with 3,4-diaminopyridine","volume":"47","author":"Uekita","year":"2009","journal-title":"Nihon Kokyuki Gakkai Zasshi"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4123\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:47:00Z","timestamp":1748753220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,18]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,18]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ol.2016.4123"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4123","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2016,1,18]]}}}